KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Convertible Debt (2020 - 2025)

Historic Convertible Debt for Guardant Health (GH) over the last 6 years, with Q3 2025 value amounting to $1.1 billion.

  • Guardant Health's Convertible Debt fell 239.14% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 239.14%. This contributed to the annual value of $1.1 billion for FY2024, which is 22.64% up from last year.
  • Latest data reveals that Guardant Health reported Convertible Debt of $1.1 billion as of Q3 2025, which was down 239.14% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Convertible Debt ranged from a high of $1.1 billion in Q4 2024 and a low of $1.1 billion during Q3 2025
  • For the 5-year period, Guardant Health's Convertible Debt averaged around $1.1 billion, with its median value being $1.1 billion (2022).
  • As far as peak fluctuations go, Guardant Health's Convertible Debt skyrocketed by 4074.57% in 2021, and later plummeted by 239.14% in 2025.
  • Guardant Health's Convertible Debt (Quarter) stood at $1.1 billion in 2021, then rose by 0.23% to $1.1 billion in 2022, then grew by 0.23% to $1.1 billion in 2023, then increased by 0.23% to $1.1 billion in 2024, then dropped by 2.45% to $1.1 billion in 2025.
  • Its Convertible Debt stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.